They are used prior to drug free treatment hut are also used in methadone maintenance for 're-stabilisation'.

33 billion. On an operational basis, worldwide sales increased by 13.2%, but were partially offset by adverse currency exchange rates 2.6% ; due to the continued strength of the U.S. dollar. Net earnings for 2001 were .7 billion, a 14.4% increase over the prior year. Earnings per share were .84, up 14.3% compared to .61 in 2000. To put our financial performance in perspective, 2001 was our 69th consecutive year of increased sales and our 17th consecutive year of double digit earnings increases excluding special charges ; . On the strength of this performance, the Board of Directors increased the quarterly dividend in April 2001 for the 39th consecutive year, from $.16 per quarter in 2000 to $.18 per quarter, an increase of 12.5%. The consistency of these measures of growth is virtually without parallel. Yet another measure of financial performance which we have focused on is cash flow from operations. "Free cash flow" defined as cash remaining after making the capital expenditures required to support the growth of our business ; is, in fact, one of the very best measures of how a company is performing. Its virtue is its clarity. You either generate cash or you don't. It is not subject to many varying interpretations or accounting changes. We are pleased to report that Johnson & Johnson's "free cash flow" reached an impressive .1 billion in 2001 -- a record -- up from .6 billion just five years ago and 0 million a decade ago. In short, your Company is growing in both sales and earnings and generating substantial levels of cash flow. The net result is that our balance sheet is exceptionally strong. Our excellent financial standing is demonstrated by our ability to implement the recently announced repurchase of up to billion of the Company's stock while maintaining our "triple A" credit rating -- a rating few companies have achieved. As importantly, our strong balance sheet gives us enormous flexibility to invest in growing the business and to seek out and act upon new opportunities -- giving us a significant competitive advantage. Our excellent financial performance reflects our ongoing efforts to root each of our broadly based health care businesses in a foundation of science and technology. Simply stated, we believe that excellence in medical. Of testosterone implants for androgen replacement therapy. Clin Endocrinol Oxf ; 47: 311316 Bailey BJ, Briars GL 1996 Estimating the surface area of the human body. Stat Med 15: 13251332 Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA 1996 Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J Clin Endocrinol Metab 81: 4113 4121 Handelsman DJ, Wishart S, Conway AJ 2000 Oestradiol enhances testosterone-induced suppression of human spermatogenesis. Hum Reprod 15: 672 679 Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI, Handelsman DJ 2003 Contraceptive efficacy of a depot progestin and androgen combination in men. J Clin Endocrinol Metab 88: 4659 4667 Hammond GL, Nisker JA, Jones LA, Siiteri PK 1980 Estimation of the percentage of free steroid in undiluted serum by centrifugal ultrafiltration-dialysis. J Biol Chem 255: 50235026 Zitzmann M, Nieschlag E 2003 The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26: 76 83 Yong EL, Loy CJ, Sim KS 2003 Androgen receptor gene and male infertility. Hum Reprod Update 9: 17 Bhasin S, Buckwalter JG 2001 Testosterone supplementation in older men: a rational idea whose time has not yet come. J Androl 22: 718 731 Gruenewald DA, Matsumoto 2003 Testosterone supplementation therapy for older men: potential benefits and risks. J Geriatr Soc 51: 101115; discussion 115 Smith KW, Feldman HA, McKinlay JB 2000 Construction and field validation of a self-administered screener for testosterone deficiency hypogonadism ; in ageing men. Clin Endocrinol Oxf ; 53: 703711 Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, Perry 3rd HM 2000 Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 49: 1239 1242 Heinemann LA, Saad F, Zimmermann T, Novak A, Myon E, Badia X, Potthoff P, T'Sjoen G, Pollanen P, Goncharow NP, Kim S, Giroudet C 2003 The aging males' symptoms AMS ; scale: update and compilation of international versions. Health Qual Life Outcomes 1: 15 Daig I, Heinemann LA, Kim S, Leungwattanakij S, Badia X, Myon E, Moore C, Saad F, Potthoff P, Thai DM 2003 The aging males' symptoms AMS ; scale: review of its methodological characteristics. Health Qual Life Outcomes 1: 77 T'Sjoen G, Goemaere S, De Meyere M, Kaufman JM 2004 Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels. Psychoneuroendocrinology 29: 201214 Semple CG, Gray CE, Beastall GH 1987 Male hypogonadism--a non-specific consequence of illness. Q J Med 64: 601 607 Gray A, Berlin JA, McKinlay JB, Longcope C 1991 An examination of research design effects on the association of testosterone and male aging: results of a meta-analysis. J Clin Epidemiol 44: 671 684 Salmimies P, Kockott G, Pirke KM, Vogt HJ, Schill WB 1982 Effects of testosterone replacement on sexual behaviour in hypogonadal men. Arch Sex Behav 11: 345353 Gooren LJG 1985 Human male sexual functions do not require aromatization of testosterone: a study using tamoxifen, testolactone, and dihydrotestosterone. Arch Sex Behav 14: 539 548 Gooren LJ 1987 Androgen levels and sex functions in testosterone-treated hypogonadal men. Arch Sex Behav 16: 463 473 Buena F, Peterson MA, Swerdloff RS, Pandian MR, Steiner BS, Galmarini M, Lutchmansingh P, Bhasin S 1993 Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 59: 1118 1123 Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ 1994 Effects of endogenous testosterone and estradiol on sexual behaviour in normal young men. J Clin Endocrinol Metab 78: 711716 Woodhouse LJ, Reisz-Porszasz S, Javanbakht M, Storer TW, Lee M, Zerounian H, Bhasin S 2003 Development of models to predict anabolic response to testosterone administration in healthy young men. J Physiol Endocrinol Metab 284: E1009 E1017 Petra P, Stanczyk FZ, Namkung PC, Fritz MA, Novy ML 1985 Direct effect of sex-steroid binding protein SBP ; of plasma on the metabolic clearance rate of testosterone in the rhesus macaque. J Steroid Biochem Mol Biol 22: 739 746 Gooren L 1988 Hypogonadotropic hypogonadal men respond less well to androgen substitution treatment than hypergonadotropic hypogonadal men. Arch Sex Behav 17: 265270 Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley Jr WF 1987 Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 106: 354 361.

Delivered in Canada? In Canada, as in many other countries, there is a national level regulatory framework for methadone prescription. The Office of Controlled Substances, Health Canada, works with provincial territorial governments and medical licensing bodies, among others, to facilitate increased access to methadone maintenance treatment. To date in addition to the Health Canada guidelines10, 11 on the use of opioids in the management of opioid dependence, several provinces have developed--or are in the process of developing-- guidelines and training for practitioners interested in providing methadone maintenance treatment. Although provinces have become increasingly involved in delineating the conditions under which they recommend to Health Canada physicians who should be allowed to prescribe methadone, only physicians who have received an exemption under Section 56 of the Controlled Drugs and Substances Act are allowed to prescribe methadone. Methadone maintenance treatment may be delivered in a variety of different settings including and methazolamide.

AB 1st trimester: More than three spontaneous or induced abortions at less than 13 weeks gestation. Do not include ectopic pregnancies. ; AB 2nd trimester: Spontaneous or induced abortion between 12 and 19 weeks gestation. Uterine anomaly: Bicornate, T-shaped, or septate uterus, etc. DES exposure: Exposure to diethylstilbesterol in utero. Patient who has anomalies associated with diethylstilbesterol receives points for this item and uterine anomaly. Hx PTL: Spontaneous preterm labor during any previous pregnancies whether or not resulting in preterm birth ; or preterm delivery. Hx pyelonephritis: One or more episodes of pyelonephritis in past medical history. Street drug use: Any street drug use during this pregnancy, e.g., speed, marijuana, cocaine, heroin includes methadone ; . Alcohol use: Consumption of 6 or more glasses of beer or wine per week or 4 or more mixed drinks per week. Includes any binge drinking. Initial prenatal visit: First prenatal visit at or after 16 weeks gestation. Poor social situation: Personal or family history of abuse, incarceration, homelessness, psychiatric disorder, child custody loss, cultural barriers, low cognitive functioning, mental retardation, negative attitude toward pregnancy, exposure to hazardous toxic agents, inadequate support system. Employment: Light work part time or sedentary work Heavy work work involving strenuous physical effort, standing, or continuous nervous tension, such as, nurses, sales staff, cleaning staff, baby-sitters, laborers Bacteriuria: Any symptomatic or asymptomatic urinary tract infection, i.e., 100, 000 colonies in urinalysis. Pyelonephritis: Diagnosed pyelonephritis in the current pregnancy. Give points for pyelonephritis only, not both pyelonephritis and bacteriuria. ; Bleeding after 12th week: Vaginal bleeding or spotting after 12 weeks of gestation of any amount, duration, or frequency which is not obviously due to cervical contact. Dilation Internal os ; : Cervical dilation of the internal os of one cm or more at 34 weeks gestation. Uterine irritability: Uterine contractions of 5 contractions in one hour perceived by patient or documented by provider without cervical change at less than 34 weeks. Surgery: Any abdominal surgery performed at 18 weeks or more of gestation or cervical cerclage at any time in this pregnancy. Febrile illness: Systemic illness such as pyelonephritis or influenza ; with temperature of 100 F or greater determined by thermometer reading on one or more occasions. Hypertension: Two measurements showing an increase of systolic pressure of 30 mgHg above baseline, an increase in diastolic pressure of 15 mgHg above baseline, or both. 470-2942 Rev. 5 03.